Skip Navigation
Search Menu

Print This Page
Share this page: More

Register for the NCCN Policy Summit: Designing Clinical Trials in the Era of Multiple Biomarkers and Targeted Therapies

WHEN:    Friday, April 25
                8:00 AM - 3: 30 PM

WHERE:  Bethesda Marriott
                5151 Pooks Hill Road
                Bethesda, MD

WHAT:  With cancers increasingly recognized as being comprised of many subtypes differentiated by specific molecular profiles, identifying the most effective combination therapies is challenging. Defining appropriate patient subsets, selecting agents active against specific targets, predicting effective therapeutic combinations and appropriately interpreting clinical trials results are significant problems for pharmaceutical companies, clinicians, statisticians and regulators which will need to be addressed in order to meet the needs of cancer patients.


8:00 – 9:00 AM -  Breakfast and Registration
9:05 – 9:20 AM - Summit Welcome
9:25 – 10:20 AM - Presentation of Conclusions and Recommendations of the Work Group
10:25 – 10:40 AM - Break
10:45 AM – 12:15 PM - Panel Discussion - Strategies for Implementation of Clinical Trials in the Era of Small Subsets and Multiple Agents
12:20 – 1:20 PM - Lunch
1:25 – 2:55 PM - Panel Discussion - Identifying and Defining Standards of Care for Cancer Subtypes
3:00 – 3:30 PM - Wrap up, Conclusions, and Next Steps

Government: $199
Health Care Professional (Other): $299
Industry: $599
Non-Profit/Academia: $299
Patient: $199
Physician: $299


For additional information, contact Elizabeth Danielson at


Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers


Chemo School & Virtual Tour

Take our video class to learn about your first steps in receiving chemotherapy Chemo School
Prepare for your first visit with this "walking" tour of our clinical facilities.  Watch the video.


Promise and Progress
The magazine of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

View all Publications


The Kimmel Wire

The Kimmel Wire

Latest News from the Kimmel Cancer Center
Subscribe Now